Laura Barton, MA, MS, CGC
Laura Barton, MA, MS, CGC
Specialty: Genetics
Program: Genetics
Language(s): English
-
Overview
Laura V. Barton is a Certified Genetic Counselor specializing in inherited cancer syndromes in the Moffitt Cancer Center Department of Personalized Medicine. She has been practicing as a genetic counselor at Moffitt for 4 years. Laura completed her Genetic Counselor training at Virginia Commonwealth University in Richmond, Virginia, and earned her undergraduate degree at the University of Central Florida. She also has a Master’s degree in Bioethics and Medical Humanities from the University of South Florida. She is board certified by the American Board of Genetic Counseling since 2012. In addition to providing genetic counseling to patients, she works closely with the Clinical Genomic Action Committee in reviewing results of tumor genomic testing to identify patients who may benefit from meeting with a genetic counselor. Laura serves on the ethics committee at Moffitt, and plays an active role in the genetic counselor training program at the University of South Florida as a clinical supervisor and lecturer.
-
Publications
- Berry DK, Gillis N, Padron E, Moore C, Barton LV, Gewandter KR, Haskins CG, Knepper TC. Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance. J Genet Couns. 2023 Sep. Pubmedid: 37715966.
- Mehta R, Sinnamon A, Dam A, Walko C, Palm R, Barton L, Lauwers G, Pimiento JM. Locally advanced mismatch repair-deficient gastroesophageal junction cancer: Diagnosis, treatment modifications, and monitoring. CA-Cancer J Clin. 2023 Oct.74(2):123-131. Pubmedid: 37849051.
- Mallen AR, Conley CC, Fuzzell L, Ketcher D, Augusto BM, McIntyre M, Barton LV, Townsend MK, Fridley BL, Tworoger SS, Wenham RM, Vadaparampil ST. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer. Support Care Cancer. 2021 May.29(5):2663-2677. Pubmedid: 32975643. Pmcid: PMC7981241.
- Janssen WE, Ribickas A, Meyer LV, Smilee RC. Large-scale Ficoll gradient separations using a commercially available, effectively closed, system. Cytotherapy. 2010 May.12(3):418-424. Pubmedid: 20184500.
-
Patient Comments
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments